 Kelly Sullivan
Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 9 | 2021 | 265 | 2.570 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2021 | 443 | 2.360 |
Why?
| | Proteome | 2 | 2021 | 312 | 1.300 |
Why?
| | Genes, p53 | 2 | 2012 | 77 | 0.980 |
Why?
| | Piperazines | 4 | 2020 | 304 | 0.920 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 25 | 0.910 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 38 | 0.900 |
Why?
| | Azetidines | 1 | 2020 | 38 | 0.900 |
Why?
| | Transcriptome | 3 | 2021 | 570 | 0.860 |
Why?
| | Apoptosis | 10 | 2020 | 2562 | 0.840 |
Why?
| | Databases, Genetic | 1 | 2021 | 270 | 0.820 |
Why?
| | Tumor Suppressor Proteins | 4 | 2018 | 285 | 0.760 |
Why?
| | Metabolome | 1 | 2021 | 280 | 0.750 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 69 | 0.740 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2015 | 57 | 0.720 |
Why?
| | Hypersensitivity | 1 | 2020 | 274 | 0.690 |
Why?
| | Interferons | 2 | 2021 | 118 | 0.690 |
Why?
| | Sulfonamides | 1 | 2020 | 399 | 0.690 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 3 | 2017 | 59 | 0.690 |
Why?
| | Transcriptional Activation | 2 | 2021 | 374 | 0.670 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1163 | 0.640 |
Why?
| | Neoplasms | 5 | 2017 | 1966 | 0.620 |
Why?
| | Isoquinolines | 1 | 2015 | 47 | 0.620 |
Why?
| | Mitochondrial Turnover | 1 | 2015 | 4 | 0.620 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 821 | 0.610 |
Why?
| | Caenorhabditis elegans Proteins | 2 | 2015 | 229 | 0.600 |
Why?
| | Immunity, Innate | 2 | 2020 | 731 | 0.570 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1413 | 0.500 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 537 | 0.490 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 67 | 0.490 |
Why?
| | Fibroblasts | 1 | 2016 | 882 | 0.460 |
Why?
| | Patient Selection | 1 | 2015 | 692 | 0.460 |
Why?
| | Imidazoles | 3 | 2020 | 263 | 0.430 |
Why?
| | Interferon-alpha | 3 | 2020 | 203 | 0.430 |
Why?
| | Cell Cycle Proteins | 2 | 2017 | 543 | 0.410 |
Why?
| | Trisomy | 2 | 2019 | 61 | 0.380 |
Why?
| | Protein-Serine-Threonine Kinases | 1 | 2012 | 609 | 0.380 |
Why?
| | Membrane Proteins | 1 | 2015 | 1044 | 0.370 |
Why?
| | Gene Expression Profiling | 4 | 2021 | 1622 | 0.360 |
Why?
| | HCT116 Cells | 3 | 2017 | 76 | 0.350 |
Why?
| | Inflammation | 1 | 2017 | 2251 | 0.330 |
Why?
| | Biomarkers | 2 | 2021 | 3322 | 0.320 |
Why?
| | Autophagy | 2 | 2018 | 296 | 0.250 |
Why?
| | Humans | 26 | 2021 | 108531 | 0.250 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 457 | 0.240 |
Why?
| | Nuclear Proteins | 3 | 2017 | 659 | 0.230 |
Why?
| | Datasets as Topic | 1 | 2021 | 85 | 0.230 |
Why?
| | Seroconversion | 1 | 2021 | 36 | 0.230 |
Why?
| | Access to Information | 1 | 2021 | 54 | 0.230 |
Why?
| | RNA Helicases | 1 | 2020 | 32 | 0.220 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 187 | 0.210 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2019 | 34 | 0.210 |
Why?
| | Data Mining | 1 | 2021 | 146 | 0.210 |
Why?
| | Receptors, Interferon | 1 | 2019 | 42 | 0.210 |
Why?
| | Protein Domains | 2 | 2017 | 210 | 0.200 |
Why?
| | Kynurenine | 1 | 2019 | 64 | 0.200 |
Why?
| | Cell Line | 5 | 2021 | 2948 | 0.200 |
Why?
| | Animals | 10 | 2021 | 34575 | 0.200 |
Why?
| | Complement System Proteins | 2 | 2021 | 232 | 0.200 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1460 | 0.200 |
Why?
| | Metabolomics | 2 | 2021 | 570 | 0.190 |
Why?
| | Centrosome | 1 | 2018 | 59 | 0.190 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 18 | 0.190 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 58 | 0.180 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 391 | 0.180 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2017 | 36 | 0.180 |
Why?
| | Signal Transduction | 4 | 2021 | 4836 | 0.180 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 4 | 0.180 |
Why?
| | Cilia | 1 | 2018 | 138 | 0.170 |
Why?
| | Cell Cycle Checkpoints | 2 | 2020 | 91 | 0.170 |
Why?
| | Hedgehog Proteins | 1 | 2018 | 167 | 0.170 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 210 | 0.170 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 350 | 0.170 |
Why?
| | Histidine Kinase | 1 | 2016 | 32 | 0.170 |
Why?
| | Caspases | 2 | 2015 | 290 | 0.170 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 440 | 0.170 |
Why?
| | Mice | 5 | 2020 | 14889 | 0.170 |
Why?
| | Proto-Oncogene Proteins | 2 | 2018 | 693 | 0.170 |
Why?
| | Antigens | 1 | 2018 | 309 | 0.170 |
Why?
| | Proteolysis | 1 | 2017 | 137 | 0.160 |
Why?
| | Cell Line, Tumor | 4 | 2018 | 2829 | 0.160 |
Why?
| | Case-Control Studies | 2 | 2021 | 3310 | 0.160 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 165 | 0.160 |
Why?
| | Genomics | 1 | 2021 | 562 | 0.160 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 219 | 0.160 |
Why?
| | Down-Regulation | 2 | 2017 | 686 | 0.160 |
Why?
| | Proteomics | 1 | 2021 | 754 | 0.160 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 177 | 0.160 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 13 | 0.150 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 5106 | 0.150 |
Why?
| | Cell Proliferation | 3 | 2018 | 2349 | 0.150 |
Why?
| | Pyrones | 1 | 2015 | 11 | 0.150 |
Why?
| | Caspase 8 | 1 | 2015 | 58 | 0.150 |
Why?
| | Young Adult | 3 | 2021 | 10690 | 0.150 |
Why?
| | bcl-2-Associated X Protein | 1 | 2015 | 52 | 0.150 |
Why?
| | Azepines | 1 | 2015 | 74 | 0.150 |
Why?
| | Fluorouracil | 1 | 2015 | 139 | 0.150 |
Why?
| | Morpholines | 1 | 2015 | 103 | 0.140 |
Why?
| | Repressor Proteins | 1 | 2017 | 379 | 0.140 |
Why?
| | Heat-Shock Proteins | 1 | 2015 | 149 | 0.140 |
Why?
| | Aminobenzoates | 1 | 2013 | 7 | 0.140 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 411 | 0.140 |
Why?
| | Cells, Cultured | 3 | 2018 | 4324 | 0.140 |
Why?
| | Autoimmunity | 1 | 2019 | 720 | 0.140 |
Why?
| | Monocytes | 1 | 2016 | 465 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 215 | 0.140 |
Why?
| | Carrier Proteins | 1 | 2018 | 814 | 0.140 |
Why?
| | Naphthalenes | 1 | 2013 | 57 | 0.130 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 543 | 0.130 |
Why?
| | Female | 8 | 2021 | 61452 | 0.130 |
Why?
| | Ligands | 1 | 2015 | 517 | 0.130 |
Why?
| | Cytokines | 2 | 2019 | 1903 | 0.130 |
Why?
| | Genes, Synthetic | 1 | 2012 | 18 | 0.130 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2015 | 142 | 0.130 |
Why?
| | Genes, Lethal | 1 | 2012 | 28 | 0.130 |
Why?
| | RNA Interference | 1 | 2015 | 508 | 0.130 |
Why?
| | Enzyme Activation | 1 | 2015 | 953 | 0.120 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 602 | 0.120 |
Why?
| | Male | 6 | 2021 | 59999 | 0.120 |
Why?
| | Liver | 1 | 2020 | 1832 | 0.120 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 908 | 0.120 |
Why?
| | Pyrimidines | 1 | 2015 | 373 | 0.120 |
Why?
| | Telomerase | 1 | 2013 | 220 | 0.120 |
Why?
| | Chronic Disease | 1 | 2017 | 1645 | 0.120 |
Why?
| | Adult | 4 | 2021 | 31352 | 0.110 |
Why?
| | Lipids | 1 | 2015 | 599 | 0.110 |
Why?
| | Caenorhabditis elegans | 1 | 2014 | 364 | 0.110 |
Why?
| | Hematopoiesis | 2 | 2021 | 177 | 0.110 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2204 | 0.110 |
Why?
| | Transcription Factors | 1 | 2018 | 1614 | 0.100 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 3119 | 0.100 |
Why?
| | Cell Cycle | 1 | 2012 | 593 | 0.100 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2590 | 0.100 |
Why?
| | Mitochondria | 1 | 2015 | 766 | 0.100 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1631 | 0.090 |
Why?
| | Mutation | 2 | 2015 | 3275 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2018 | 1858 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2147 | 0.080 |
Why?
| | Infant | 1 | 2017 | 7842 | 0.070 |
Why?
| | Child, Preschool | 1 | 2017 | 9438 | 0.070 |
Why?
| | Middle Aged | 2 | 2021 | 28413 | 0.070 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 20 | 0.060 |
Why?
| | Protein Binding | 2 | 2020 | 2096 | 0.060 |
Why?
| | Clonal Evolution | 1 | 2021 | 28 | 0.060 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 127 | 0.060 |
Why?
| | Binding Sites | 2 | 2014 | 1316 | 0.060 |
Why?
| | Polyribosomes | 1 | 2020 | 25 | 0.050 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 36 | 0.050 |
Why?
| | Quinolinic Acid | 1 | 2019 | 9 | 0.050 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 17 | 0.050 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 43 | 0.050 |
Why?
| | Gene Silencing | 1 | 2020 | 187 | 0.050 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 163 | 0.050 |
Why?
| | Child | 1 | 2017 | 16520 | 0.050 |
Why?
| | Adolescent | 1 | 2017 | 18140 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2019 | 139 | 0.050 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 78 | 0.050 |
Why?
| | Hexokinase | 1 | 2017 | 10 | 0.050 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 39 | 0.050 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 11 | 0.050 |
Why?
| | Complement Activation | 1 | 2021 | 312 | 0.050 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 43 | 0.050 |
Why?
| | Deoxyglucose | 1 | 2017 | 59 | 0.050 |
Why?
| | MCF-7 Cells | 1 | 2017 | 104 | 0.040 |
Why?
| | Gene Editing | 1 | 2017 | 54 | 0.040 |
Why?
| | Cell Lineage | 1 | 2019 | 358 | 0.040 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 13 | 0.040 |
Why?
| | Homeostasis | 1 | 2021 | 566 | 0.040 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2017 | 111 | 0.040 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 26 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 326 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 405 | 0.040 |
Why?
| | Purines | 1 | 2017 | 152 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2017 | 245 | 0.040 |
Why?
| | Glycolysis | 1 | 2017 | 230 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 441 | 0.040 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 60 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 1018 | 0.040 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 96 | 0.040 |
Why?
| | Comorbidity | 1 | 2021 | 1569 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2019 | 786 | 0.040 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 17 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2019 | 1168 | 0.040 |
Why?
| | Base Sequence | 1 | 2020 | 2327 | 0.040 |
Why?
| | Aurora Kinase A | 1 | 2015 | 49 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1118 | 0.040 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 39 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 632 | 0.040 |
Why?
| | Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2013 | 10 | 0.040 |
Why?
| | Serine Proteases | 1 | 2013 | 16 | 0.030 |
Why?
| | Aminopeptidases | 1 | 2013 | 14 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1578 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 898 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 947 | 0.030 |
Why?
| | Protein Transport | 1 | 2014 | 449 | 0.030 |
Why?
| | Chromatin | 1 | 2016 | 418 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1855 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 347 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1547 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 767 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2017 | 1049 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2019 | 1735 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 2980 | 0.030 |
Why?
| | HeLa Cells | 1 | 2013 | 638 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2020 | 2906 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 999 | 0.030 |
Why?
| | Cell Survival | 1 | 2013 | 1126 | 0.030 |
Why?
| | RNA | 1 | 2014 | 759 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 3845 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2038 | 0.020 |
Why?
|
|
Sullivan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|